Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Cytarabine × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 33 Burkitt Lymphoma 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia, Biphenotypic, Acute 7 Myelodysplastic Syndromes 5 Leukemia, Myelomonocytic, Chronic 4 Leukemia 4 Recurrence 3 Myeloproliferative Disorders 3 Lymphoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Hematologic Neoplasms 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Sarcoma, Myeloid 1 Rasmussen subacute encephalitis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Myasthenia Gravis 1 Medulloblastoma 1 Lymphoma, Follicular 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1

Interventions

pembrolizumab 2 fludarabine 2 blinatumomab 2 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 relugolix 1 nilotinib 1 isatuximab 1 inavolisib 1 giredestrant 1 fludarabine phosphate 1 enzalutamide 1 abemaciclib 1 Transplantation 1 Monatide (IMS 3015) 1 Melphalan 1 Lenalidomide 1 Immunotherapy 1 Imatinib Mesylate 1 HMPL-013 1 Docetaxel 1 Dexamethasone 1 Dasatinib 1 Cyclophosphamide 1 Capecitabine 1 Calcium Dobesilate 1 Biological Assay 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡